An in-vivo pilot study into the effects of FDG-mNP in cancer in mice Journal Article


Authors: Aras, O.; Pearce, G.; Watkins, A. J.; Nurili, F.; Medine, E. I.; Guldu, O. K.; Tekin, V.; Wong, J.; Ma, X.; Ting, R.; Unak, P.; Akin, O.
Article Title: An in-vivo pilot study into the effects of FDG-mNP in cancer in mice
Abstract: Purpose Previously, fluorodeoxy glucose conjugated magnetite nanoparticles (FDG-mNPs) injected into cancer cells in conjunction with the application of magnetic hyperthermia have shown promise in new FDG-mNPs applications. The aim of this study was to determine potential toxic or unwanted effects involving both tumour cells and normal tissue in other organs when FDG-mNPs are administered intravenously or intratumourally in mice. Materials and methods FDG-mNPs were synthesized. A group of six prostate-tumour bearing mice were injected with 23.42 mg/ml FDG-mNPs (intravenous injection, n = 3; intratumoural injection into the prostate tumour, n = 3). Mice were euthanized and histological sampling of tissue was conducted for the prostate tumour, as well as for lungs, lymph nodes, liver, kidneys, spleen, and brain, at 1 hour (n = 2) and 7 days (n = 4) post-injection. A second group of two normal (noncancerous) mice received the same injection intravenously into the tail vein and were euthanised at 3 and 6 months post-injection, respectively, to investigate if FDG-mNPs remained in organs at those time points. Results In prostate-tumour bearing mice, FDG-mNPs concentrated in the prostate tumour, while relatively small amounts were found in the organs of other tissues, particularly the spleen and the liver; FDG-mNP concentrations decreased over time in all tissues. In normal mice, no detrimental effects were found in either mouse at 3 or 6 months. Conclusion Intravenous or intratumoural FDG-mNPs can be safely administered for effective cancer cell destruction. Further research on the clinical utility of FDG-mNPs will be conducted by applying hyperthermia in conjunction with FDG-mNPs in mice. This is an open access article, free of all copyright, and may be freely reproduced, distributed, transmitted, modified, built upon, or otherwise used by anyone for any lawful purpose. The work is made available under the Creative Commons CC0 public domain dedication.
Journal Title: PLoS ONE
Volume: 13
Issue: 8
ISSN: 1932-6203
Publisher: Public Library of Science  
Date Published: 2018-08-20
Start Page: e0202482
Language: English
DOI: 10.1371/journal.pone.0202482
PROVIDER: scopus
PMCID: PMC6101388
PUBMED: 30125303
DOI/URL:
Notes: Article -- Export Date: 4 September 2018 -- Source: Scopus
Altmetric
Citation Impact
BMJ Impact Analytics
MSK Authors
  1. Oguz Akin
    265 Akin
  2. Omer Aras
    76 Aras
  3. Fuad Nurili
    24 Nurili
  4. Emin Ilker Medine
    2 Medine